Guidelines : Actinic keratosis
Detail
Condition :
Actinic keratosis
Keywords :
solar, AK, solaraze, efudix, aldara, actikerall, picato, zyclara, fluorouracil, diclofenac, ingenol, imiquimod, solacutan
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
03 June 2020
The APC recommends primary care treatment choices for actinic keratosis as follows:
GREEN traffic light status:
Fluorouracil (Efudix®)
Diclofenac 3% gel (Solaraze® or Solacutan®)
BLUE (without an information sheet) traffic light status:
Fluorouracil & salicylic acid solution (Actikerall®)
Imiquimod 5% cream (Aldara®)
BLACK traffic light status:
Imiquimod 3.75% (Zyclara®)
Ingenol mebutate gel (Picato®)
See Actinic Keratosis Guidelines below
N/A
Documents
Type
Document
Review Date
Guidelines (Local)
November 2022
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Actinic keratosis.
- Aminolaevulinic Acid (Alacare medicated plasters)
- Aminolaevulinic Acid (Ameluz gel) Red
- Diclofenac 3% Green
- Fluorouracil 5% cream Green
- Fluorouracil/Salicylic Acid Blue
- Imiquimod 3.75% Black
- Imiquimod 5% Blue
- Ingenol Mebutate Black
- Tirbanibulin See narrative